Neuroprotection Exploratory Trials in Parkinson's Disease: NET-PD National Institute of Neurological Disorders and Stroke logo
National Institutes of Health
NET-PD Home
[What is the NET-PD Study?]
[Who is sponsoring NET-PD?]
[What drugs are being studied?]
[Where can I participate?]
[Am I eligible?]
[FAQs]
[Study publications]
[Privacy and confidentiality]
[En EspaƱol]
[For more information, call toll free 1-800-352-9424 email  info@parkinsontrial.org or visit clinicaltrials.gov.] info@partkinsontrial.org clinicaltrials.gov Learn more about NET-PD clinical trials for Parkinson's Disease
[Parkinson's Study]


The National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, is looking for individuals with Parkinson's disease to participate in NIH Exploratory Trials in Parkinson's Disease (NET-PD). NET-PD is a series of clinical research studies conducted at more than 50 centers across the country and in Canada in an effort to find drugs to slow the progression of Parkinson's.

Current therapies are able to effectively treat the symptoms of PD. However, over time, these therapies may be less effective and the disease process continues. Therefore it is important to identify agents that are able to slow disease progression.

Recruitment is currently underway for a large study of the nutritional supplement creatine.
See the Study Synopsis



[Participating in a clinical study allows you to play an active role in developing future treatments for Parkinson's disease.]

NET-PD Home | What is the NET-PD Study? | Who is sponsoring NET-PD? | What drugs are being studied?
Where can I participate? | Am I eligible? | FAQs | Study publications | Privacy and confidentiality | NINDS Home

U.S. Department of Health and Human Services logo     National Institutes of Health logo     National Institute of Neurological Disorders and Stroke logo     USA.gov logo